These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31781598)

  • 21. Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
    Turajlic S; Litchfield K; Xu H; Rosenthal R; McGranahan N; Reading JL; Wong YNS; Rowan A; Kanu N; Al Bakir M; Chambers T; Salgado R; Savas P; Loi S; Birkbak NJ; Sansregret L; Gore M; Larkin J; Quezada SA; Swanton C
    Lancet Oncol; 2017 Aug; 18(8):1009-1021. PubMed ID: 28694034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.
    Zhou S; Liu S; Zhao L; Sun HX
    Front Oncol; 2022; 12():786438. PubMed ID: 35387130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer.
    Liang H; Xu Y; Chen M; Zhao J; Zhong W; Liu X; Gao X; Li S; Li J; Guo C; Jia H; Wang M
    Front Immunol; 2021; 12():749461. PubMed ID: 35356154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens.
    Khodadoust MS; Olsson N; Wagar LE; Haabeth OA; Chen B; Swaminathan K; Rawson K; Liu CL; Steiner D; Lund P; Rao S; Zhang L; Marceau C; Stehr H; Newman AM; Czerwinski DK; Carlton VE; Moorhead M; Faham M; Kohrt HE; Carette J; Green MR; Davis MM; Levy R; Elias JE; Alizadeh AA
    Nature; 2017 Mar; 543(7647):723-727. PubMed ID: 28329770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.
    Kim JY; Lee E; Park K; Park WY; Jung HH; Ahn JS; Im YH; Park YH
    Oncotarget; 2017 Apr; 8(17):27997-28007. PubMed ID: 28427202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancer Neoantigens Can Induce CD8
    Zhang X; Kim S; Hundal J; Herndon JM; Li S; Petti AA; Soysal SD; Li L; McLellan MD; Hoog J; Primeau T; Myers N; Vickery TL; Sturmoski M; Hagemann IS; Miller CA; Ellis MJ; Mardis ER; Hansen T; Fleming TP; Goedegebuure SP; Gillanders WE
    Cancer Immunol Res; 2017 Jul; 5(7):516-523. PubMed ID: 28619968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public neoantigens in breast cancer immunotherapy (Review).
    Sueangoen N; Thuwajit P; Yenchitsomanus PT; Thuwajit C
    Int J Mol Med; 2024 Jul; 54(1):. PubMed ID: 38904202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
    Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer.
    Lo W; Parkhurst M; Robbins PF; Tran E; Lu YC; Jia L; Gartner JJ; Pasetto A; Deniger D; Malekzadeh P; Shelton TE; Prickett T; Ray S; Kivitz S; Paria BC; Kriley I; Schrump DS; Rosenberg SA
    Cancer Immunol Res; 2019 Apr; 7(4):534-543. PubMed ID: 30709841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies.
    Lo AA; Wallace A; Oreper D; Lounsbury N; Havnar C; Pechuan-Jorge X; Wu TD; Bourgon R; Jones R; Krogh K; Yang GY; Zill OA
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads.
    Lussier DM; Alspach E; Ward JP; Miceli AP; Runci D; White JM; Mpoy C; Arthur CD; Kohlmiller HN; Jacks T; Artyomov MN; Rogers BE; Schreiber RD
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34099555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer.
    Yin Q; Tang J; Zhu X
    Brief Funct Genomics; 2019 Mar; 18(2):119-128. PubMed ID: 29982317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Neoantigens for Personalised Immunotherapy.
    Pritchard AL
    BioDrugs; 2018 Apr; 32(2):99-109. PubMed ID: 29516371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. neoANT-HILL: an integrated tool for identification of potential neoantigens.
    Coelho ACMF; Fonseca AL; Martins DL; Lins PBR; da Cunha LM; de Souza SJ
    BMC Med Genomics; 2020 Feb; 13(1):30. PubMed ID: 32087727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
    Ren Y; Cherukuri Y; Wickland DP; Sarangi V; Tian S; Carter JM; Mansfield AS; Block MS; Sherman ME; Knutson KL; Lin Y; Asmann YW
    Oncoimmunology; 2020; 9(1):1744947. PubMed ID: 32523802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer immunotherapy targeting neoantigens.
    Lu YC; Robbins PF
    Semin Immunol; 2016 Feb; 28(1):22-7. PubMed ID: 26653770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
    Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
    Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of
    Shen X; Zhao Y; Chen X; Sun H; Liu M; Zhang W; Jiang F; Li P
    Future Oncol; 2019 Jun; 15(16):1873-1894. PubMed ID: 30920860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.